AZD0292

Multispecific antibody

Earlyevidence

Evidence outlook

Early-stage evidence only

Phase 1 / first-in-human studies establish safety, tolerability, and dosing; they are not designed to demonstrate efficacy, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 2 (2)
Other / comorbidity
NCT07088926 · AstraZeneca
2025-11-06 – 2028-06-14 · Bronchiectasis With Pseudomonas Aeruginosa Colonization
What this study did
NCT07774403 · AstraZeneca
2026-06-24 – 2028-06-06 · Bronchiectasis With Pseudomonas Aeruginosa Colonization
What this study did
Phase 1 (2)
Other / comorbidity
NCT07222254 · AstraZeneca
2025-12-12 – 2026-07-30 · Healthy Participants
What this study did
NCT06311760 · AstraZeneca
2024-04-09 – 2025-02-20 · Healthy Participants Study
What this study did

Competitive landscape

This drug's own stage for Non-Cystic Fibrosis Bronchiectasis: Stage not on record. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
AZD0292: this drugStage not on recordMultispecific antibodyPseudomonas aeruginosa Psl / PcrVnot yet gradedNo reviewed efficacy summary in this indication
GSK3862995
Phase 1(overall)
Monoclonal antibodyIL-33not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(2 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow AZD0292 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
December 2027 (1)
Phase 2Bronchiectasis With Pseudomonas Aeruginosa ColonizationRecruiting
Est. primary completion 2027-12-09 · NCT07088926 · CT.gov ↗
What to watch
2028 (1)
January 2028 (1)
Phase 2Bronchiectasis With Pseudomonas Aeruginosa ColonizationRecruiting
Est. primary completion 2028-01-18 · NCT07774403 · CT.gov ↗
What to watch

See the full readout calendar ↗